A&T

A&T Corporation is a Japanese medical technology company specializing in the development, manufacturing, and sale of clinical laboratory equipment and reagents. The company is a leader in laboratory automation systems (LAS) and clinical chemistry analyzers, particularly known for its high-precision electrolyte testing technology. A&T provides integrated solutions that include laboratory information systems (LIS) to optimize hospital workflow and diagnostic accuracy. Founded in 1978 and headquartered in Yokohama, the company has a strong presence in the Asian in vitro diagnostics (IVD) market. In 2021, A&T was acquired by Arkray, Inc., a global leader in diabetes monitoring, and was subsequently delisted from the Tokyo Stock Exchange. The company continues to operate as a key subsidiary of Arkray, focusing on the synergy between laboratory automation and clinical testing.